214 related articles for article (PubMed ID: 30168875)
21. Hypochondroplasia and Acanthosis nigricans: a new syndrome due to the p.Lys650Thr mutation in the fibroblast growth factor receptor 3 gene?
Castro-Feijóo L; Loidi L; Vidal A; Parajes S; Rosón E; Alvarez A; Cabanas P; Barreiro J; Alonso A; Domínguez F; Pombo M
Eur J Endocrinol; 2008 Sep; 159(3):243-9. PubMed ID: 18583390
[TBL] [Abstract][Full Text] [Related]
22. New Magnetic Resonance Imaging (MRI) findings in a patient with hypochondroplasia caused by the FGFR3 N540K variant.
Mimura PMP; Castro JTS; Jarry VM; França Júnior MC; Reis F
Arq Neuropsiquiatr; 2021 Jul; 79(7):656-657. PubMed ID: 34133497
[No Abstract] [Full Text] [Related]
23. Homozygous N540K hypochondroplasia--first report: radiological and clinical features.
De Rosa ML; Fano V; Araoz HV; Chertkoff L; Obregon MG
Am J Med Genet A; 2014 Jul; 164A(7):1784-8. PubMed ID: 24715719
[TBL] [Abstract][Full Text] [Related]
24. Effects of glycolic acid peeling on the cutaneous manifestation of generalized acanthosis nigricans caused by FGFR3 mutation: A report of one sporadic and two familial cases.
Ichiyama S; Kubo A; Matayoshi T; Saeki H; Funasaka Y
J Dermatol; 2017 Oct; 44(10):e250-e251. PubMed ID: 28620983
[No Abstract] [Full Text] [Related]
25. Earlier detection of hypochondroplasia: A large single-center UK case series and systematic review.
Sabir AH; Sheikh J; Singh A; Morley E; Cocca A; Cheung MS; Irving M
Am J Med Genet A; 2021 Jan; 185(1):73-82. PubMed ID: 33051983
[TBL] [Abstract][Full Text] [Related]
26. Detection of a de novo Y278C mutation in FGFR3 in a pregnancy with severe fetal hypochondroplasia: prenatal diagnosis and literature review.
Chen CP; Su YN; Lin TH; Chang TY; Su JW; Wang W
Taiwan J Obstet Gynecol; 2013 Dec; 52(4):580-5. PubMed ID: 24411048
[TBL] [Abstract][Full Text] [Related]
27. Temporal and occipital lobe features in children with hypochondroplasia/FGFR3 gene mutation.
Philpott CM; Widjaja E; Raybaud C; Branson HM; Kannu P; Blaser S
Pediatr Radiol; 2013 Sep; 43(9):1190-5. PubMed ID: 23649205
[TBL] [Abstract][Full Text] [Related]
28. Epileptic phenotype of FGFR3-related bilateral medial temporal lobe dysgenesis.
Okazaki T; Saito Y; Ueda R; Awashima T; Nishimura Y; Yuasa I; Shinohara Y; Adachi K; Sasaki M; Nanba E; Maegaki Y
Brain Dev; 2017 Jan; 39(1):67-71. PubMed ID: 27485793
[TBL] [Abstract][Full Text] [Related]
29. FGFR3-related hypochondroplasia: longitudinal growth in 57 children with the p.Asn540Lys mutation.
Arenas MA; Del Pino M; Fano V
J Pediatr Endocrinol Metab; 2018 Nov; 31(11):1279-1284. PubMed ID: 30335613
[TBL] [Abstract][Full Text] [Related]
30. Clinical and radiologic evaluation of a Turkish family with hypochondroplasia and a rare
Ekinci S; Ülger Y; Acar MO; Ceran A; Aycan Z; Fitoz ÖS; Ilgın Ruhi H
J Pediatr Endocrinol Metab; 2022 Aug; 35(8):1097-1101. PubMed ID: 35438268
[TBL] [Abstract][Full Text] [Related]
31. ASN540SER mutation is associated with a mild form of hypochondroplasia: a 7 years follow-up in an Italian boy.
De Sanctis V; Baldi M; Marsciani A; Ravaioli E; Timoncini G; Reggiani L; Sensi A; Zucchini A
Georgian Med News; 2012 Sep; (210):77-82. PubMed ID: 23045425
[TBL] [Abstract][Full Text] [Related]
32. Effective treatment by glycolic acid peeling for cutaneous manifestation of familial generalized acanthosis nigricans caused by FGFR3 mutation.
Ichiyama S; Funasaka Y; Otsuka Y; Takayama R; Kawana S; Saeki H; Kubo A
J Eur Acad Dermatol Venereol; 2016 Mar; 30(3):442-5. PubMed ID: 26818779
[TBL] [Abstract][Full Text] [Related]
33. [Clinical analysis and genetic diagnosis of short-limb inherited short stature diseases in children].
Li F; Ma HW; Song Y; Hu M; Ren S; Yu YF; Zhao GJ
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Nov; 15(11):932-6. PubMed ID: 24229583
[TBL] [Abstract][Full Text] [Related]
34. Topical sirolimus therapy for epidermal nevus with features of acanthosis nigricans.
Dodds M; Maguiness S
Pediatr Dermatol; 2019 Jul; 36(4):554-555. PubMed ID: 30983034
[TBL] [Abstract][Full Text] [Related]
35. Achondroplasia-First Report from India of a Rare FGFR3 Gene Variant.
Chaudhry C; G P; Srivastava P; Das R; Kaur J; Panigrahi I; Kaur A
Lab Med; 2021 Sep; 52(5):499-502. PubMed ID: 33511985
[TBL] [Abstract][Full Text] [Related]
36. Hypochondroplasia, Acanthosis Nigricans, and Insulin Resistance in a Child with FGFR3 Mutation: Is It Just an Association?
Mustafa M; Moghrabi N; Bin-Abbas B
Case Rep Endocrinol; 2014; 2014():840492. PubMed ID: 25505998
[TBL] [Abstract][Full Text] [Related]
37. High-Resolution Melting Analysis for Rapid Detection of Mutations in Patients with
Riba FRG; Gomes MES; Rabelo NC; Zuma MCC; Llerena JC; Mencalha AL; Gonzalez S
Genet Test Mol Biomarkers; 2021 Oct; 25(10):674-682. PubMed ID: 34672771
[No Abstract] [Full Text] [Related]
38. Low bone mineral density in achondroplasia and hypochondroplasia.
Matsushita M; Kitoh H; Mishima K; Kadono I; Sugiura H; Hasegawa S; Nishida Y; Ishiguro N
Pediatr Int; 2016 Aug; 58(8):705-8. PubMed ID: 26716907
[TBL] [Abstract][Full Text] [Related]
39. Mosaic mutations in FGFR3 and FGFR2 are associated with naevoid acanthosis nigricans or RAVEN (round and velvety epidermal naevus).
Larsabal M; Cogrel O; Caumont C; Jegou MH; Taïeb A; Morice-Picard F
Br J Dermatol; 2019 Jan; 180(1):201-202. PubMed ID: 30117157
[No Abstract] [Full Text] [Related]
40. A novel skeletal dysplasia with developmental delay and acanthosis nigricans is caused by a Lys650Met mutation in the fibroblast growth factor receptor 3 gene.
Tavormina PL; Bellus GA; Webster MK; Bamshad MJ; Fraley AE; McIntosh I; Szabo J; Jiang W; Jabs EW; Wilcox WR; Wasmuth JJ; Donoghue DJ; Thompson LM; Francomano CA
Am J Hum Genet; 1999 Mar; 64(3):722-31. PubMed ID: 10053006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
